Welcome to ChiRhoClin, Inc.

We have exciting news and information about both diagnostic drugs: Synthetic Porcine Secretin and Synthetic Human Secretin (ChiRhoStim™).

To access information on ChiRhoClin new Clinical Studies visit our publication section.

We invite you to look around the ChiRhoClin website.  ChiRhoClin continues to provide support for regulatory and NDA related activities to BioTech and Pharmaceutical Companies.

ChiRhoStim™ (Human Secretin for injection) is now commercially available.

ChiRhoStim™ is now reimbursable with J-Code 2850 effective January 1^st 2006

ChiRhoStim™ (Human Secretin for injection) has superior stability and storage:  24 months in freezer (-20°C)
                                                                                                                                             12 months in refrigerator (4-8°C)
                                                                                                                                               6 months at room temperature

Access Human Secretin for Injection package insert at the products section.

To order contact your wholesaler or call 1-877-CRC-4888.  For more information please visit www.human-secretin.com

ChiRhoClin Mission

Our mission is to provide high-quality peptide and protein-based drug products for the GI community.  Our continuing mission is to develop orphan drug products that will aid, treat, and diagnose Gastrointestinal diseases.

Company Profile

ChiRhoClin, Inc., a Maryland based corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D.  ChiRhoClin is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products.  

The company also provides contract services to the pharmaceutical industry in areas including regulatory support, clinical and medical monitoring, report writing, safety surveillance,  pharmacokinetics,  pharmacodynamics and biostatistics.  

ChiRhoClin received approval from the FDA on April 5, 2002 to manufacture and market  synthetic porcine secretin.  

 ChiRhoClin, Inc. Received FDA approval on April 9th, 2004 to manufacture and market ChiRhoStim™ (Human Secretin for injection).

Contact Information

If you have any questions please contact us at.

Telephone: 301-476-8388 or 1-877-272-4888

 

Fax: 301-476-9529

                                               

Postal address:

ChiRhoClin, Inc.

          4000 Blackburn Lane

Suite 270

Burtonsville, MD 20866

 

E-mail:

www.ChiRhoClin@ChiRhoClin.com